Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2026-04-19 @ 11:09 PM
Study NCT ID:
NCT02297503
Status:
COMPLETED
Last Update Posted:
2022-08-26
First Post:
2014-10-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-31
First Submit QC Date:
None
Study First Post Date:
2014-11-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-25
Results First Submit QC Date:
None
Results First Post Date:
2019-09-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-24
Last Update Post Date:
2022-08-26
Last Update Post Date Type:
ACTUAL